US Government and Novartis AG in $486 Million Flu Vaccine Deal

ZURICH, Jan 15 (Reuters) - The U.S. government has awarded Novartis AG a contract worth up to $486 million over eight years to build a plant to manufacture influenza vaccine for use in case of a pandemic, the Swiss drugmaker said.